| Name | Title | Contact Details |
|---|
Aurora Financial Services is a Aurora, ON-based company in the Business Services sector.
Bukhatir Group is a New York, NY-based company in the Business Services sector.
Life Chiropractic College West is a chiropractic educational institution located in Hayward, California. Established in 1976 and renamed in 1981, the college focuses on training chiropractors through a comprehensive curriculum that combines clinical training, philosophical principles, and patient-centered care. Its mission is to empower students to "Create a Brighter Future for Humanity" by promoting values of giving, doing, loving, and serving. The college offers a Doctor of Chiropractic Program that emphasizes hands-on clinical experience and competency in patient care. It also provides continuing education courses for practicing chiropractors to enhance their skills. Life West is dedicated to fostering a unique institutional culture and expanding chiropractic accessibility worldwide. The college serves prospective students, practicing chiropractors, and global communities, aiming to produce graduates who contribute to the advancement of chiropractic care on an international scale.
Morettis Design Collection Inc is a Carson, CA-based company in the Business Services sector.
Biocartis is a molecular diagnostics company based in Mechelen, Belgium, founded in 2007. The company focuses on enhancing molecular testing through its proprietary Idylla TM Platform, which aims to make personalized medicine accessible by providing fast and convenient testing solutions suitable for various laboratory settings. Biocartis specializes in oncology diagnostics, offering a range of tests for cancers such as melanoma, colorectal, lung, brain, blood, and breast cancer. The Idylla Platform is a fully automated system that utilizes real-time PCR technology, enabling rapid in-house testing with results available in 30 to 150 minutes. In addition to oncology, Biocartis develops tests for infectious diseases, including panels for SARS-CoV-2, flu, and RSV, as well as the SeptiCyte RAPID test for host response. The company collaborates with major pharmaceutical and biotechnology firms, including Amgen and Bristol-Myers Squibb, to advance its testing capabilities and expand its diagnostic applications. Biocartis is committed to developing four to five new diagnostic applications each year, further enhancing its impact in the molecular diagnostics field.